This is a free website for Nuclear Medicine Technologists and Students who wish to broaden their understanding of Nuclear Cardiology Practices and Principles.



home
Syllabus
Glossary
Gallery

1a: History
1b: Guidelines
1c: Epidemiology
1d: Structure
1e: Circulation
Lesson 1 REVIEW

2a: Anomalies
2b: Dextrocardia
2c: Coronary Arteries
2d: Indicators of Function
Lesson 2 REVIEW

3a: Electrophysiology
3b: Conduction
3c: Action Potential
3d: Autonomic System
Lesson 3 REVIEW

4a: Electrocardiography
4b: EKG Slideshow
4c: EKG Interpretation
4d: Myocardial Damage
Lesson 4 REVIEW

5a: Cardiovascular Disease
5b: Coronary Syndromes
5c: Atherosclerosis
5d: Myocardial Infarction
5e: Cardiac Stress Testing
5f: Cardiac Medications
5g: Revascularization
Lesson 5 REVIEW

6a: Diagnostic Imaging
6b: Radiopharmaceuticals
6c: Thallium Scintigraphy
6d: Tc99m MPI Agents
6e: PET Imaging
6f: Blood Pool Imaging
6g: Cardiac Function
Lesson 6 REVIEW

7a: Planar Cardiac Imaging
7b: Cardiac SPECT Imaging
7c: Cardiac SPECT Anatomy
7d: Interpretation
7e: Attenuation Correction
Lesson 7 REVIEW

Gallery

 

 

LESSON 6f page 4

CARDIAC BLOOD POOL IMAGING

GATED TOMOGRAPHIC RADIONUCLIDE ANGIOGRAPHY (SPECT MUGA)

It has recently become possible to combine gated blood pool imaging with photon emission computed tomography (SPECT). It allows the automated identification of the left ventricular surface in gated tomographic radionuclide ventriculograms. Data can be displayed in three dimensions. It has been shown that the regurgitation fraction in patients with mitral and aortic insufficiency is accurately measured by gated radionuclide angiography SPECT imaging. Although the resolution of gated SPECT is not as high as magnetic resonance imaging, it is relatively inexpensive and provides an accurate picture of ventricular function.


FORMULATION PROBLEMS WITH TAGGED RBC'S

FORMULATION PROBLEM

CLINICAL MANIFESTATION

 

Carrier 99Tc (especially with AC)

labeling efficiency; free pertechnetate

 

Al3+

RBC agglutination

 

Very acidic pH

RBC hemolysis

 

Inadequate stannous

free pertechnetate

 

Excessive stannous

plasma activity, spleen uptake

 

Excessive 99mTc activity added

rate and extent of labeling

 

Improper mixing order

liver uptake; labeling efficiency

 

Low cell concentration

rate and extent of labeling

 

Radiolytic decomposition and/or oxidation

free pertechnetate

 

Inadequate incubation time

free pertechnetate

 

Incubation at < 37 C

rate of labeling; free pertechnetate

 

Heparin vs ACD

labeling efficiency; extravascular activity; urinary excretion  
ACD vs heparin stability; blood/background ratio  
EDTA as the anticoagulant labeling efficiency  
Excess ACD

sequestration in spleen; labeling efficiency

 

Large volume of pertechnetate solution

rate and extent of labeling

 

Inadequate volume of blood

labeling efficiency

 

EDTA as a sequesterant

blood pool retention; splenic accumulation

 
     

DRUG INTERFERENCE   Agents that alter, by direct pharmacological effect, cardiac function and have the potential to interfere with interpretation of the gated blood pool study:

- beta blockers (propranolol, 48 hr)
- calcium channel blockers (verapamil, 48-72 hrs)
- nitrates (nitroglycerin, 12 hr)


REASONS FOR ERROR IN EJECTION FRACTION DETERMINATION

OVERESTIMATION OF EF VALUES

  • Background ROI placed too close to or over activity in spleen or descending aorta

  • ROI too large (but does not include LA)

  • Patients with postero-basal aneurysm

UNDERESTIMATION OF EF VALUES

  • Inclusion of LA in left ventricular ROI, particularly at end diastole

  • Poor separation of left and right ventricles

  • Using a fixed ROI

  • End-systolic ROI too large

  • Inclusion of ascending aorta in end-diastolic ROI

  • Placement of background ROI over photopenic area

  • ECG gating problems

  • Poor definition of true end-systolic volume (inadequate temporal resolution)

  • Patients with antero-apical aneurysm or markedly enlarged LV

 

MUGA TROUBLE SHOOTING

Problem

Possible Causes

Remedies

Blurry Study

low counts

poor target to background

 

dose infiltrated

very obese patient

off peak

bad lot of Pyrophosphate
heparin or other drug

reinject 5 mCi Tc-99m or re-peak

send vials to drug company

redo with labeled HSA

 

Not gating well
missing beats
R wave too low Switch leads to find highest R wave


Not gating well

atrial fibrillation

wide variability R-R’s widen beat acceptance window


Not gating well

atrial, ventricular arrhythmias

wide variability R-R’s

Patience

If persistent biventricular bigeminy, reschedule patient

Not gating well

paced rhythm

dual chamber; gating on atrial and ventricular artifacts Call EP group to put magnet on pacemaker to change VVI


Big hot spleen

malignancy In the lateral view make sure the heart is in FOV
Heart not beating in lateral view ECG lead off put lead back on and repeat view
Complex cardiac anatomy and difficulty finding best septal angle complex CHF marked dilation of one chamber

Ask MD for assistance

Take ANT or LAT

No zoom for anatomy
Poor gating during first stages exercise poor lead contact Stop exercise, replace all leads and electrodes, have patient exercise briefly to make sure signal stable before restarting. Drop of normal saline on skin under electrode.
In 3 view MUGA one image looks “asystolic” Lost gate or ECG lead Repeat that view
     

 

  page:

1

2

3

4

5

next
 
 
 

  syllabus - terms of use - bibliography - contact